ARGX – argenx se - american depositary shares (US:NASDAQ)
Stock Stats
News
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
argenx to Present at TD Cowen 46th Annual Healthcare Conference
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
Form 6-K ARGENX SE For: Dec 31
Form 6-K ARGENX SE For: Feb 26
Form 6-K ARGENX SE For: Jan 13
Form 6-K ARGENX SE For: Jan 12
Form 6-K ARGENX SE For: Jan 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.